These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 25838319)

  • 1. Atypical neuroleptic malignant syndrome in patients treated with aripiprazole and clozapine: a case-series study and short review.
    Tseng PT; Chang YC; Chang CH; Wang HY; Cheng YS; Wu CK; Chen YW; Chung W
    Int J Psychiatry Med; 2015; 49(1):35-43. PubMed ID: 25838319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extreme elevation of creatinine phosphokinase levels in neuroleptic malignant syndrome associated with atypical antipsychotics.
    Ladds B; Thomas P; Mejia C; Hauser D
    Am J Psychiatry; 2009 Jan; 166(1):114-5. PubMed ID: 19122020
    [No Abstract]   [Full Text] [Related]  

  • 3. Neuroleptic malignant syndrome secondary to aripiprazole initiation in a clozapine-intolerant patient.
    Patel MK; Brunetti L
    Am J Health Syst Pharm; 2010 Aug; 67(15):1254-9. PubMed ID: 20651315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clozapine-associated neuroleptic malignant syndrome followed by catatonia: a case report].
    Erol A; Putgül G; Sert E; Mete L
    Turk Psikiyatri Derg; 2013; 24(2):140-4. PubMed ID: 23754268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clozapine: a neuroleptic at risk of provoking neuroleptic malignant syndrome (NMS) or an alternative neuroleptic with positive NMS case histories?].
    Weller M; Kornhuber J
    Fortschr Neurol Psychiatr; 1993 Jun; 61(6):217-22. PubMed ID: 8330832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
    Khaldi S; Kornreich C; Choubani Z; Gourevitch R
    Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case report of neuroleptic malignant syndrome without fever in a patient given aripiprazole.
    Rodriguez OP; Dowell MS
    J Okla State Med Assoc; 2006; 99(7):435-8. PubMed ID: 17017330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neuroleptic malignant syndrome after 30 years treatment with clozapine: a rarely seen differential diagnosis on intensive care units].
    Franzen D; Burkhard J; Corti N; Schüpbach D; Fontanel D; Stäubli M
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2006 Feb; 41(2):125-7. PubMed ID: 16493563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aripiprazole and neuroleptic malignant syndrome.
    Chakraborty N; Johnston T
    Int Clin Psychopharmacol; 2004 Nov; 19(6):351-3. PubMed ID: 15486522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefits of combining aripiprazole to clozapine: three case reports.
    Rocha FL; Hara C
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1167-9. PubMed ID: 16647796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aripiprazole in treatment-refractory schizophrenia.
    Hsu WY; Lee CI; Chiu NY; Kahn DA
    J Psychiatr Pract; 2009 May; 15(3):221-6. PubMed ID: 19461396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroleptic malignant syndrome and clozapine.
    Reddig S; Minnema AM; Tandon R
    Ann Clin Psychiatry; 1993 Mar; 5(1):25-7. PubMed ID: 8102300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fever, confusion, acute kidney injury: is this atypical neuroleptic malignant syndrome following polypharmacy with clozapine and risperidone?
    Cherry S; Siskind D; Spivak V; Wysoczanski D; Halangoda P
    Australas Psychiatry; 2016 Dec; 24(6):602-603. PubMed ID: 27194777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroleptic rechallenge with aripiprazole in a patient with previously documented neuroleptic malignant syndrome.
    Trutia A; Bledowski J; Pandurangi A; Kahn DA
    J Psychiatr Pract; 2008 Nov; 14(6):398-402. PubMed ID: 19057242
    [No Abstract]   [Full Text] [Related]  

  • 15. Neuroleptic malignant syndrome associated with atypical antipsychotics in pediatric patients: a review of published cases.
    Croarkin PE; Emslie GJ; Mayes TL
    J Clin Psychiatry; 2008 Jul; 69(7):1157-65. PubMed ID: 18572981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NMS after clozapine initiation.
    Skarpathiotakis M; Westreich N
    J Am Acad Child Adolesc Psychiatry; 2005 Nov; 44(11):1101-2. PubMed ID: 16239854
    [No Abstract]   [Full Text] [Related]  

  • 17. Clozapine-induced neuroleptic malignant syndrome.
    DasGupta K; Young A
    J Clin Psychiatry; 1991 Mar; 52(3):105-7. PubMed ID: 2005072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychosis or atypical neuroleptic malignant syndrome in an adolescent?
    Groff K; Coffey BJ
    J Child Adolesc Psychopharmacol; 2008 Oct; 18(5):529-32. PubMed ID: 18928418
    [No Abstract]   [Full Text] [Related]  

  • 19. Catatonia as a risk factor for the development of neuroleptic malignant syndrome: report of a case following treatment with clozapine.
    Paparrigopoulos T; Tzavellas E; Ferentinos P; Mourikis I; Liappas J
    World J Biol Psychiatry; 2009; 10(1):70-3. PubMed ID: 19673089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ziprasidone- and lithium-induced neuroleptic malignant syndrome.
    Borovicka MC; Bond LC; Gaughan KM
    Ann Pharmacother; 2006 Jan; 40(1):139-42. PubMed ID: 16352776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.